Omada Health Shares Soar After IPO as GLP-1 Drugs Fuel Interest - WSJ

Read also:

• U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - Merck.com
• Big Match & Segment Announced for June 6 WWE SmackDown - Ringside News
• Samsung Nears Wide-Ranging Deal With Perplexity for AI Features - Bloomberg.com
• Why are right-wing commentators spreading conspiracy theories about Haitians eating local pets in Springfield, Ohio?
• What great song was "ruined" once you really listened to the lyrics?
• This Type of Fiber Could Have Weight Loss Benefits Similar to Ozempic - ScienceAlert
• Bond Yields Keeping Climbing. Governments Can Bring Them Down. - Barron's
• Scientists make jaw-dropping find after drilling more than 1,500 feet into Antarctic ice: 'We even discovered a school of lobster-like creatures' - The Cool Down
• Colonoscopy screening at age 45 yields neoplasia rates close to older adults: Study supports guideline change - Medical Xpress
• How do I get over a long-term relationship breakup?
• Being fat is a trap - Hacker News